A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MS

NCT07222956 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis (MS) - Relapsing-remitting
Multiple Sclerosis (MS) Secondary Progressive
Multiple Sclerosis (MS) Primary Progressive

Interventions

DRUG: Remibrutinib (Open Label)

Sponsor

Moein Amin

Collaborators

[object Object]